Cargando…

Mechanical effects of midwall fibrosis in non-ischemic dilated cardiomyopathy

Detalles Bibliográficos
Autores principales:	Taylor, Robin J, Umar, Fraz, Lin, Lai Sze, Ahmed, Amar, Moody, William E, Stegemann, Berthold, Townend, John N, Steeds, Richard P, Leyva, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044213/ http://dx.doi.org/10.1186/1532-429X-16-S1-P308

Ejemplares similares

Mechanical effects of left ventricular midwall fibrosis in non-ischemic cardiomyopathy
por: Taylor, Robin J., et al.
Publicado: (2016)

Prognostic significance of midwall fibrosis in dilated cardiomyopathy
por: Gulati, Ankur, et al.
Publicado: (2012)

Evaluating the significance of left ventricular midwall fibrosis detected by late gadolinium enhancement imaging on left ventricular functional remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2016)

Comparison of magnetic resonance feature tracking for longitudinal strain calculation with spatial modulation of magnetization imaging analysis
por: Moody, William E, et al.
Publicado: (2013)

Left ventricular midwall fibrosis as a predictor of sudden cardiac death in non‐ischaemic dilated cardiomyopathy: a meta‐analysis
por: Wang, Jie, et al.
Publicado: (2020)

Midwall Fibrosis and Cardiac Mechanics: Rigid Body Rotation Is a Novel Marker of Disease Severity in Pediatric Primary Dilated Cardiomyopathy
por: Al-Wakeel-Marquard, Nadya, et al.
Publicado: (2022)

Reply to: Left ventricular midwall fibrosis as a predictor of sudden cardiac death in non‐ischaemic dilated cardiomyopathy: a meta‐analysis
por: Wang, Jie, et al.
Publicado: (2021)

Correlation between septal midwall late gadolinium enhancement on CMR and conduction delay on ECG in patients with nonischemic dilated cardiomyopathy
por: Becker, Marthe A.J., et al.
Publicado: (2020)

Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction
por: Halliday, Brian P., et al.
Publicado: (2017)

Impaired circumferential and longitudinal myocardial deformation in early stage chronic kidney disease: the earliest features of uremic cardiomyopathy
por: Edwards, Nicola C, et al.
Publicado: (2013)

Early stage chronic kidney disease: a paradigm for diffuse fibrosis and clinical progression
por: Edwards, Nicola C, et al.
Publicado: (2014)

Left ventricle restoration in end stage ischemic dilated cardiomyopathy
por: Jonjev, Z
Publicado: (2013)

Parameters of Right Ventricle as etiological distinction between ischemic and non-ischemic dilated cardiomyopathy
por: Gomes, Hélder Andrade, et al.
Publicado: (2015)

Comparison of Semi-automated Late Gadolinium Enhancement Quantification Techniques in Measuring Septal Fibrosis in Patients with Dilated Non-Ischemic Cardiomyopathy
por: Mikami, Yoko, et al.
Publicado: (2016)

Left atrial volume is associated with mid-wall fibrosis in Dilated Cardiomyopathy
por: Fanaie, Fariba, et al.
Publicado: (2011)

The association between ECV and microcirculation perfusion abnormalities in non-ischemic dilated cardiomyopathy
por: Ali, Aamir, et al.
Publicado: (2014)

Immunoadsorption in dilated cardiomyopathy
por: Wakabayashi, Y, et al.
Publicado: (2009)

Myocardial fibrosis is not associated with reduced quality of life in patients with dilated or hypertrophic cardiomyopathy
por: Khan, Razi, et al.
Publicado: (2011)

Association of LA volumes and mid-wall myocardial fibrosis in the Dilated cardiomyopathy patients
por: Fanaie, Fariba, et al.
Publicado: (2011)

Right ventricular function in dilated cardiomyopathy: relation to location of focal myocardial fibrosis
por: Abdelrazek, Mohamed A, et al.
Publicado: (2013)

Diffuse fibrosis in dilated cardiomyopathy results in a shorter myocardial null time
por: Han, Yuchi, et al.
Publicado: (2009)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Regional diffuse fibrosis and strain characteristics differ between children with hypertrophic and dilated cardiomyopathy
por: Patel, Jyoti K, et al.
Publicado: (2015)

Prognostic implication of liver fibrosis scores in patients with non-ischemic dilated cardiomyopathy
por: Liu, Yupeng, et al.
Publicado: (2023)

Normative annual changes in left ventricular volumes, mass and function among healthy adults: a prospective cardiac magnetic resonance imaging study
por: Moody, William E, et al.
Publicado: (2014)

Greyzone myocardial fibrosis and ventricular arrhythmias in patients with a left ventricular ejection fraction >35%
por: Zegard, Abbasin, et al.
Publicado: (2021)

Utility of Native T1 mapping to differentiate between athlete's heart and non-ischemic dilated cardiomyopathy
por: Mordi, Ify, et al.
Publicado: (2015)

Midwall ejection fraction for assessing systolic performance of the hypertrophic left ventricle
por: Yoshikawa, Hisao, et al.
Publicado: (2012)

Myocardial fibrosis is a predictor of atrial fibrillation in dilated cardiomyopathy. Role of cardiovascular magnetic resonance
por: Almeida, Ana G, et al.
Publicado: (2011)

The quantification and role of diffuse myocardial fibrosis in familial dilated cardiomyopathy - an equilibrium contrast cmr study
por: Sado, Daniel M, et al.
Publicado: (2011)

Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy
por: Leyva, Francisco, et al.
Publicado: (2018)

Native left ventricular myocardial T(1) spatial heterogeneity in non-ischemic dilated cardiomyopathy
por: Kashem, Abyaad, et al.
Publicado: (2016)

Cardiac Magnetic Resonance for evaluating early outcomes of stem cell therapy in non-ischemic dilated cardiomyopathy
por: Gulati, Gurpreet S, et al.
Publicado: (2011)

Epicardial adipose tissue evaluated with cardiac magnetic resonance in normal subject and in patients with ischemic and dilated cardiomyopathies
por: Secchi, Francesco, et al.
Publicado: (2016)

Bio-imaging: late gadolinium enhancement in dilated cardiomyopathy and its relation to novel biomarkers of fibrosis and remodeling
por: Abdel-Aty, Hassan, et al.
Publicado: (2013)

Normal Ranges and Physiological Changes of Midwall Fractional Shortening in Healthy Korean Population
por: Park, Kyungil, et al.
Publicado: (2010)

Quantitative assessment of myocardial extracellular volume fraction in non-ischemic dilated cardiomyopathy and its relation to systolic dysfunction
por: Ali, Aamir, et al.
Publicado: (2013)

Predicting mortality in patients with non-ischemic dilative cardiomyopathy: Potential of extracellular volume imaging by cardiovascular magnetic resonance
por: Koopmann, Katharina, et al.
Publicado: (2014)

The Ubiquitin Proteasome System in Ischemic and Dilated Cardiomyopathy
por: Spänig, Sabine, et al.
Publicado: (2019)

Energy Metabolites as Biomarkers in Ischemic and Dilated Cardiomyopathy
por: Haas, Jan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_stuq6h01m71uf4duu0hi6clr8h